We are live on ! Find out more
OGEN icon

Oragenics
OGEN

13 hedge funds and large institutions have $10.5M invested in Oragenics in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $9M → $10.5M (+$1.53M)

0% more funds holding

Funds holding: 13 → 13 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$18.6K
2
VKH
Virtu KCG Holdings
New York
+$18.6K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$9.28K
4
UBS Group
UBS Group
Switzerland
+$9.28K

Top Sellers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
-$27.8K
2
Brown Advisory
Brown Advisory
Maryland
-$23K
3
MLM
Mount Lucas Management
Pennsylvania
-$16K
4
Goldman Sachs
Goldman Sachs
New York
-$9.28K
5
Squarepoint
Squarepoint
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$8.36M – – –
MP
2
MSD Partners
New York
$932K – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$900K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$103K +$18.6K +2 +22%
BCM
5
Bridgeway Capital Management
Texas
$78K -$27.8K -3 -27%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$48K – – –
Goldman Sachs
7
Goldman Sachs
New York
$21K -$9.28K -1 -33%
IA
8
IFP Advisors
Florida
$17K – – –
VKH
9
Virtu KCG Holdings
New York
$16K +$18.6K +2 New
Northern Trust
10
Northern Trust
Illinois
$13K – – –
GC
11
Guggenheim Capital
Illinois
$10K – – –
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$9K +$9.28K +1 New
HWM
13
Holloway Wealth Management
Florida
$7K – – –
UBS Group
14
UBS Group
Switzerland
$7K +$9.28K +1 New
BFA
15
BlackRock Fund Advisors
California
$3K – – –
Creative Planning
16
Creative Planning
Kansas
$3K – – –
Manulife (Manufacturers Life Insurance)
17
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
Bank of America
18
Bank of America
North Carolina
$1K – – –
Brown Advisory
19
Brown Advisory
Maryland
– -$23K -3 Closed
MLM
20
Mount Lucas Management
Pennsylvania
– -$16K -2 Closed
Squarepoint
21
Squarepoint
New York
– -$6K -1 Closed

OGEN Hedge Fund Activity: Q4 2016 in Review

13 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2016, worth a combined $10.5M — up 17% from $9M a quarter earlier.

Fund positioning in OGEN was balanced in Q4 2016: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $18.6K. The largest seller was Bridgeway Capital Management, cutting an estimated $27.8K.

  • 13 institutional investors held Oragenics (OGEN) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $10.5M of Oragenics stock for Q4 2016, up 17% quarter-over-quarter.
  • 3 funds opened new Oragenics positions in Q4 2016 and 3 closed out, a net change of 0 holders.
  • The largest Oragenics buyer in Q4 2016 was Vanguard Group, an estimated $18.6K added.
  • The largest Oragenics seller in Q4 2016 was Bridgeway Capital Management, an estimated $27.8K sold.

Based on aggregated 13F filings for Q4 2016.